Facebook Linkedin RSS Twitter Youtube
Home 2024

Zika virus

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA
GEN Edge

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA

Zika and Dengue Infections Differentiated Using Epitope Surrogate Technology
Infectious Diseases

Zika and Dengue Infections Differentiated Using Epitope Surrogate Technology

Viral RNA-Based Diagnostics: Nanopore System May Outperform PCR
Featured

Viral RNA-Based Diagnostics: Nanopore System May Outperform PCR

Immune Response and Not Acute Viral Infections Found Responsible for Neurological Damage
News

Immune Response and Not Acute Viral Infections Found Responsible for Neurological Damage

Zika Slows Fetal Growth and Alters Mother-Infant Interactions in Monkeys
Infectious Diseases

Zika Slows Fetal Growth and Alters Mother-Infant Interactions in Monkeys

How siRNA Protects Mosquitoes from Viral Infections Like Zika and Dengue
Infectious Diseases

How siRNA Protects Mosquitoes from Viral Infections Like Zika and Dengue

Antiviral Peptoids Target Lipid to Burst Bubble-Like Membranes
Infectious Diseases

Antiviral Peptoids Target Lipid to Burst Bubble-Like Membranes

Uncommon Antibody Provides Ultrapotent Protection against Zika Virus
Drug Discovery

Uncommon Antibody Provides Ultrapotent Protection against Zika Virus

Zika Vaccine Targeting Nonstructural Viral Proteins Found Effective in Mice
Drug Discovery

Zika Vaccine Targeting Nonstructural Viral Proteins Found Effective in Mice

What’s Next for mRNA Vaccines?
Cancer

What’s Next for mRNA Vaccines?

123...10Page 1 of 10
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.